Latest Insider Transactions at Icu Medical Inc (ICUI)
This section provides a real-time view of insider transactions for Icu Medical Inc (ICUI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ICU MEDICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ICU MEDICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2021
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,599
-21.13%
|
-
|
|
Mar 06
2021
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,039
+28.63%
|
-
|
|
Mar 06
2021
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
1,267
-7.56%
|
-
|
|
Mar 06
2021
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,862
+14.58%
|
-
|
|
Mar 06
2021
|
Kevin J Mc Grody Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,351
-12.63%
|
-
|
|
Mar 06
2021
|
Kevin J Mc Grody Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,568
+19.33%
|
-
|
|
Mar 06
2021
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,194
-6.59%
|
-
|
|
Mar 06
2021
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,168
+11.12%
|
-
|
|
Mar 06
2021
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,103
-7.93%
|
-
|
|
Mar 06
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,897
+12.99%
|
-
|
|
Mar 06
2021
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,196
-19.17%
|
-
|
|
Mar 06
2021
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,272
+26.51%
|
-
|
|
Mar 02
2021
|
Robert S Swinney Director |
SELL
Open market or private sale
|
Direct |
1,500
-6.25%
|
$310,500
$207.0 P/Share
|
|
Feb 18
2021
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
554
-22.14%
|
-
|
|
Feb 18
2021
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,005
+28.66%
|
-
|
|
Feb 18
2021
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
377
-5.43%
|
-
|
|
Feb 18
2021
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
804
+10.38%
|
-
|
|
Feb 18
2021
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,235
-29.65%
|
-
|
|
Feb 18
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,044
+36.02%
|
-
|
|
Feb 18
2021
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,873
-17.11%
|
-
|
|
Feb 18
2021
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,519
+24.32%
|
-
|
|
Feb 02
2021
|
Robert S Swinney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+5.88%
|
$64,500
$43.12 P/Share
|
|
Jan 08
2021
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
38,591
-36.81%
|
$8,490,020
$220.0 P/Share
|
|
Jan 08
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
38,591
+26.91%
|
$2,238,278
$58.79 P/Share
|
|
Jan 07
2021
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
6,070
-8.39%
|
$1,335,400
$220.0 P/Share
|
|
Jan 07
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,070
+7.74%
|
$352,060
$58.79 P/Share
|
|
Jan 06
2021
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
24,339
-26.87%
|
$5,354,580
$220.0 P/Share
|
|
Jan 06
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,339
+12.59%
|
$1,411,662
$58.79 P/Share
|
|
Jan 04
2021
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
11,500
-1.96%
|
$2,438,000
$212.87 P/Share
|
|
Jan 04
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+12.89%
|
$667,000
$58.79 P/Share
|
|
Dec 04
2020
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
9,200
-12.2%
|
$1,794,000
$195.0 P/Share
|
|
Dec 04
2020
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,200
+10.87%
|
$533,600
$58.79 P/Share
|
|
Dec 03
2020
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
2,300
-3.36%
|
$448,500
$195.0 P/Share
|
|
Dec 03
2020
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,300
+3.25%
|
$133,400
$58.79 P/Share
|
|
Nov 12
2020
|
George A Lopez Director |
SELL
Open market or private sale
|
Direct |
17,000
-2.25%
|
$3,315,000
$195.02 P/Share
|
|
Nov 12
2020
|
George A Lopez Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
17,000
+6.2%
|
$782,000
$46.53 P/Share
|
|
Nov 11
2020
|
George A Lopez Director |
SELL
Open market or private sale
|
Direct |
23,000
-1.29%
|
$4,462,000
$194.5 P/Share
|
|
Nov 11
2020
|
George A Lopez Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
23,000
+4.25%
|
$1,058,000
$46.53 P/Share
|
|
Nov 06
2020
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
11,500
-14.79%
|
$2,242,500
$195.0 P/Share
|
|
Nov 06
2020
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+12.89%
|
$667,000
$58.79 P/Share
|
|
Oct 16
2020
|
Robert S Swinney Director |
SELL
Open market or private sale
|
Direct |
277
-1.22%
|
$55,954
$202.22 P/Share
|
|
Oct 16
2020
|
Robert S Swinney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+6.18%
|
$54,000
$36.6 P/Share
|
|
Oct 09
2020
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
11,500
-14.79%
|
$2,242,500
$195.0 P/Share
|
|
Oct 09
2020
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+12.89%
|
$667,000
$58.79 P/Share
|
|
Nov 15
2018
|
Pfizer Inc Director |
SELL
Open market or private sale
|
Indirect |
2,500,000
-100.0%
|
$522,500,000
$209.25 P/Share
|
|
Aug 13
2018
|
Pfizer Inc Director |
SELL
Open market or private sale
|
Indirect |
700,000
-21.88%
|
$198,800,000
$284.35 P/Share
|